- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03728738
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke (ZODIAC)
March 28, 2020 updated by: Anne Alexandrov, University of Tennessee Health Science Center
Placing the head of bed (HOB) at 0-degrees has been shown in small studies to improve blood flow to the brain in patients with ischemic stroke caused by large artery occlusions, thereby reducing stroke symptom worsening.
This simple yet potentially impactful intervention has yet to be tested in a large clinical trial in hyperacute large artery ischemic stroke patients, but may provide nurses with a powerful contribution to acute stroke care that is capable of preventing worsening of stroke symptoms and promoting stabilization.
Because stroke is the leading cause of preventable long-term disability in adults, this study may show that simple methods such as 0-degree HOB positioning should be considered one of the very first actions taken in the emergent management of acute ischemic stroke patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Positioning of the patient during hyperacute ischemic stroke (AIS) treatment is an important, yet understudied aspect of nursing care that could impact the course of treatment and clinical outcome.
Since 1968, clinical symptom worsening in AIS patients has been documented with the head of bed (HOB) elevated to 30 degrees or higher, while clinical improvement or symptom stability has been noted with zero degree HOB positioning.
Mechanisms for zero degree HOB clinical improvement include favorable gravitational blood flow conditions and recruitment of collateral blood channels, while in the case of treatment with clot-busting medications, increased blood flow may allow more medication to reach occluded arteries facilitating clot breakdown.
Despite this, there is currently divide within the clinical community about what position is best for patients, although it has been argued that zero degree head positioning should be among the first steps taken to improve blood flow to the brain and prevent stroke symptom worsening.
The investigators have shown that elevated ICP is absent in early AIS, and that pneumonia is rare using these piloted methods.
However, no large clinical trial has examined efficacy and safety of zero degree HOB positioning within hyperacute large vessel occlusion (LVO) ischemic stroke patients with potentially viable brain tissue, leaving the acute stroke community confused as to what constitutes best practice.
ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial of head positioning to determine if zero degree HOB positioning during the early phase of hyperacute LVO ischemic stroke management prevents neurological symptom worsening.
Mechanical thrombectomy (MT) eligible patients (n=182) will be randomized to one of two groups: 1) Zero degree HOB positioning; or, 2) thirty degree HOB positioning.
The hypothesis is that optimal HOB position can be determined by early neurological symptom worsening during the intervention (Aim 1) prior to initiation of the thrombectomy procedure, and the investigators propose that real-time deterioration may be a surrogate measure for decreased downstream perfusion, potentially impacting viability of brain at risk for infarction.
Aim 2 will confirm that use of zero degree HOB positioning for AIS is safe.
Use of this nursing measure holds significant promise as an innovative adjunct method to improve AIS symptoms, and ultimately reduce disability.
Study Type
Interventional
Enrollment (Anticipated)
182
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephanie Breuer, MS
- Phone Number: 901-448-6424
- Email: sbreuer@uthsc.edu
Study Locations
-
-
Alabama
-
Mobile, Alabama, United States, 36607
- Recruiting
- Mobile Infirmary Medical Center
-
Contact:
- Jackie Owens, MSN
- Email: Jackie.Owens@InfirmaryHealth.org
-
-
California
-
Los Angeles, California, United States, 90095
- Not yet recruiting
- Ronald Reagan UCLA Medical Center
-
Contact:
- David Liebeskind, MD
-
Modesto, California, United States, 95350
- Recruiting
- Doctors Medical Center
-
Contact:
- Dharati Trivedi, MS
- Email: Dharati.Trivedi@tenethealth.com
-
-
Illinois
-
Winfield, Illinois, United States, 60190
- Recruiting
- Northwestern Central DuPage Hospital
-
Contact:
- Abbigayle Doerr, DNP
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Recruiting
- University of Louisville Hospital
-
Contact:
- Betsy Wise, MSN
-
-
North Carolina
-
Greensboro, North Carolina, United States, 27401
- Not yet recruiting
- Moses Cone Medical Center
-
Contact:
- Sharon Biby, MSN
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74136
- Recruiting
- Saint Francis Health System
-
Contact:
- Matthew Holzmann, MSN
- Email: MJHolzmann@saintfrancis.com
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Recruiting
- Hershey Medical Center - Penn State Health
-
Contact:
- Alicia Richardson, MSN
- Email: arichardson2@pennstatehealth.psu.edu
-
-
Tennessee
-
Memphis, Tennessee, United States, 38104
- Recruiting
- Methodist University Hospital
-
Contact:
- Anne W Alexandrov, PhD
-
-
Texas
-
Fort Worth, Texas, United States, 76104
- Recruiting
- Medical City - Fort Worth
-
Contact:
- Cara Guthrie-Chu, MSN
-
Houston, Texas, United States, 77030
- Recruiting
- Memorial Hermann Hospital
-
Contact:
- Nicole Gonzales, MD
- Email: Nicole.R.Gonzales@uth.tmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ischemic stroke symptoms consistent with large artery occlusion
- Baseline standard of care non-contrast head CT (or MRI) negative for hemorrhage or mass-effect
- Evidence of arterial occlusion on standard of care CT angiography or MR angiography
- Favorable neuroimaging (Alberta Stroke Program Early Computed Tomography Score [ASPECTS] > 6 in anterior circulation stroke; not applicable in posterior circulation stroke)
- Ordered treatment with mechanical thrombectomy
- Pre-stroke baseline modified Rankin Score (mRS) < 1
- Ability to enroll, randomize and begin the intervention within the Emergency Department
Exclusion Criteria:
- Non-English speaking subjects will be excluded due to use of English language instruments (modified Rankin Scale [mRS] & NIHSS) and English speaking investigators
- Pregnancy or suspicion of pregnancy
- Evidence or suspicion of vomiting any time prior to consent which could predispose to aspiration pneumonia and therefore confound determination of protocol safety
- Anticipated palliative care referral
- Evidence of evolving malignant infarction on admission noncontrast CT (or MRI)
- Need for intubation with mechanical ventilation, or non-invasive ventilatory support with either bi-level positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP)
- Inability to tolerate zero-degree positioning due to congestive heart failure, preexisting pneumonia, chronic obstructive pulmonary disease, or other medical condition
- Admission chest radiograph positive for pleural effusion, pulmonary edema, pneumonia, or other pulmonary condition that may confound determination of protocol safety
- Abnormal breath sounds on admission assessment that may confound determination of protocol safety
- Lack of a telephone and/or permanent address predisposing patients to be lost to follow up
- Enrollment in another clinical trial that may affect our primary or secondary endpoints
- In the absence of a consenting legal next of kin, any medical, psychological, cognitive, social or legal condition that would interfere with informed consent and/or capacity to comply with all study requirements, including the necessary time commitment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Zero Degree HOB
Randomization to zero degree head of bed positioning until the time of initiation of thrombectomy
|
The head of bed (HOB) position will be selected through computerized randomization, and will include either zero degree positioning or thirty degree HOB elevation
|
Active Comparator: Thirty Degree HOB
Randomization to thirty degree head of bed positioning until the time of initiation of thrombectomy
|
The head of bed (HOB) position will be selected through computerized randomization, and will include either zero degree positioning or thirty degree HOB elevation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Early Neurologic Deterioration (END) on the National Institute of Health Stroke Scale Occurring During the Positioning Intervention
Time Frame: Measured every 10 minutes from initiation of positioning up until thrombectomy commences or 2 hours - whichever comes first
|
Two or more point-worsening in the National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score during the positioning intervention period.
|
Measured every 10 minutes from initiation of positioning up until thrombectomy commences or 2 hours - whichever comes first
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Severe Neurological Deterioration (SND) on the National Institute of Health Stroke Scale Occurring During the Positioning Intervention
Time Frame: Measured every 10 minutes from initiation of positioning up until thrombectomy commences or 2 hours - whichever comes first
|
Four or more point-worsening in the National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score during the positioning intervention period.
|
Measured every 10 minutes from initiation of positioning up until thrombectomy commences or 2 hours - whichever comes first
|
Diagnosis of Pneumonia Made During Hospitalization in a Patient Free From Pneumonia at Time of Hospital Admission
Time Frame: Measured up until hospital discharge or day 7 (whichever comes first)
|
Documented onset of a new or progressive infiltrate on pulmonary imaging along with the presence of at least two of the following - Fever of 38°C/100.4°F;
Purulent sputum; Leukocytosis or leukopenia; and/or, Decline in oxygen saturation.
|
Measured up until hospital discharge or day 7 (whichever comes first)
|
Participant Deaths within 90-days from Stroke Onset
Time Frame: Up until 90-days from stroke onset
|
All cause death occurring from time of randomization up until 90-days from stroke onset
|
Up until 90-days from stroke onset
|
National Institutes of Health Stroke Scale Score at Hospital Discharge or Day 7
Time Frame: Measured at hospital discharge or by day 7 (whichever comes first)
|
Total National Institute of Health Stroke Scale (stroke disability severity measure, ranging from 0-no disability, to 42-severely disabled) score measured at the time of hospital discharge or on day 7
|
Measured at hospital discharge or by day 7 (whichever comes first)
|
Modified Rankin Scale Score at Hospital Discharge or Day 7
Time Frame: Measured at hospital discharge or on day 7 (whichever comes first)
|
Categorical rank on the Modified Rankin Scale score (stroke functional outcome measure ranging from 0-no functional disability, to 6-dead) measured at the time of hospital discharge or on day 7 (whichever comes first)
|
Measured at hospital discharge or on day 7 (whichever comes first)
|
Modified Rankin Scale Score at 90-days from Stroke Onset
Time Frame: Measured at 90 days from Stroke Onset
|
Categorical rank on the Modified Rankin Scale score (stroke functional outcome measure ranging from 0-no functional disability, to 6-dead) measured at 90 days from stroke onset
|
Measured at 90 days from Stroke Onset
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Anne W Alexandrov, PhD, University of Tennessee Health Science Center at Memphis
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 25, 2018
Primary Completion (Anticipated)
June 30, 2022
Study Completion (Anticipated)
June 30, 2023
Study Registration Dates
First Submitted
October 23, 2018
First Submitted That Met QC Criteria
October 30, 2018
First Posted (Actual)
November 2, 2018
Study Record Updates
Last Update Posted (Actual)
March 31, 2020
Last Update Submitted That Met QC Criteria
March 28, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01NR017850-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, France, Slovakia, Austria, Czechi... and more
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on Head of Bed Positioning
-
Vanderbilt UniversityCompletedRespiratory FailureUnited States
-
Bartın UnıversityRecruiting
-
Red Salud Materno Infantil y del DesarrolloHospital Universitario 12 de OctubreCompletedNeonatal DisorderSpain
-
Englewood Hospital and Medical CenterWithdrawn
-
Regional Hospital LiberecCharles University, Czech Republic; University of Sao Paulo; Technology Agency...Recruiting
-
Necmettin Erbakan UniversityCompletedSurgery | Thyroid | Nursing Caries
-
Oslo University HospitalUnknownCorneal Dystrophies, Hereditary | Fuchs' Endothelial Dystrophy | Corneal Transplantation | Descemet Stripping Automated Endothelial KeratoplastyNorway
-
PulmonarCompletedSleep Apnea Syndromes | Sleep Apnea, Obstructive | SleepBrazil
-
Hospices Civils de LyonCompleted
-
National University of SingaporeRecruiting